Prof. Lana E. Kandalaft is the Chief of Clinical and Translational Research at Swiss Medical Network. With over a decade of leadership experience, she previously directed the Center of Experimental Therapeutics at CHUV, where she developed a comprehensive structure integrating clinical research, immunotherapy manufacturing, and analytical platforms within the oncology department. Her work focuses on advancing innovative therapies from the laboratory to clinical application.
Prof. Kandalaft has also held the position of Director of Clinical Translation at the Lausanne branch of the Ludwig Institute for Cancer Research and serves as an Associate Professor at the University of Lausanne. She is an internationally recognized expert in clinical trial design, regulatory processes, translational research and most importantly cancer vaccine development with over 100 scientific publications to her name.
At the Genolier Campus, Prof. Kandalaft is leading the establishment of a center for clinical and translational research, which includes a Phase I trial unit to facilitate the development of groundbreaking treatments.
